Alternatives to Omnix Medical

AI-driven digital twin of embryo development for cell-based therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered insights platform for life sciences and biotech workflows.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

AI-powered blood test for early cancer detection and subtyping.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Compressing biology to develop the next generation of therapies.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Cloud-based platform for reproducible computational research in life sciences.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.

EU-based company providing personalized medicine solutions for medical practitioners.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Developing novel therapeutic approaches for ocular diseases.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Drug discovery and development company using a novel technological approach.

Clinical-stage biotech developing novel therapeutics for hematological malignancies and disorders.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

AI-enabled technology for cell biology research and biopharma development.

Transforming healthcare by turning scientific fiction into scientific facts.

Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.

Leveraging AI and novel technology to extract deep health insights from routine blood tests.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.

Biopharmaceutical startup developing novel therapies for rare genetic diseases.

Developing universal donor-free red blood cells for life-saving transfusions and advanced therapies.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-driven platform for protein-level disease mapping and drug discovery.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Biotechnology company developing novel therapies for multiple myeloma.

Own Chemex.ai today. Secure checkout and guided transfer support. No hidden fees.

Synthetic biology platform for environmental sustainability solutions.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Galimedix Therapeutics is a clinical-stage biopharmaceutical company developing novel radiopharmaceuticals for PET imaging.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Developing novel therapeutics targeting the tumor microenvironment for cancer treatment.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Leveraging the adaptive immune system to diagnose and treat disease.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.